Cidara Thera
(CDTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,749 | -55,728 | -42,300 | -30,043 | -13,398 |
| Depreciation Amortization | 180 | 652 | 541 | 375 | 178 |
| Accounts receivable | N/A | N/A | -337 | -215 | N/A |
| Other Working Capital | 381 | -579 | -2,846 | 476 | -2,344 |
| Other Operating Activity | 1,466 | 5,746 | 4,524 | 2,857 | 1,046 |
| Operating Cash Flow | $-14,722 | $-49,909 | $-40,418 | $-26,550 | $-14,518 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 482 | 4,777 | 9,420 | 19,300 | 11,400 |
| PPE Investments | -31 | -306 | -166 | -175 | -116 |
| Investing Cash Flow | $451 | $4,471 | $9,254 | $19,125 | $11,284 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,468 | 20,963 | 152 | 149 | 144 |
| Common Stock Repurchased | N/A | -79 | -79 | -79 | -79 |
| Financing Cash Flow | $6,468 | $20,884 | $73 | $70 | $65 |
| Beginning Cash Position | 60,813 | 85,367 | 85,367 | 85,367 | 85,367 |
| End Cash Position | 53,010 | 60,813 | 54,276 | 78,012 | 82,198 |
| Net Cash Flow | $-7,803 | $-24,554 | $-31,091 | $-7,355 | $-3,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,722 | -49,909 | -40,418 | -26,550 | -14,518 |
| Capital Expenditure | -31 | -306 | -166 | -175 | -116 |
| Free Cash Flow | -14,753 | -50,215 | -40,584 | -26,725 | -14,634 |